Year |
Citation |
Score |
2020 |
Yang M, Schell M, Loboda A, Nebozhyn M, Pledger WJ, Yeatman T. Abstract 5789: A novel role of APC-partnering mutations in the sidedness of colorectal cancer survival Cancer Research. 80: 5789-5789. DOI: 10.1158/1538-7445.Am2020-5789 |
0.313 |
|
2018 |
Lo FY, Olson C, Deutsch K, Saloranta T, Golez I, Yeatman T, Anderson S, Madan A. Abstract 5379: Stratification of colorectal cancer patients based on various sequencing platforms and tumor mutational burden Cancer Research. 78: 5379-5379. DOI: 10.1158/1538-7445.Am2018-5379 |
0.384 |
|
2017 |
Lo FY, Mandloi N, Yeatman T, Paul K, Patil A, Anderson S, Gupta R, Madan A. Abstract 413: Neo-epitope detection and immune infiltrate analysis of colorectal cancer samples Cancer Research. 77: 413-413. DOI: 10.1158/1538-7445.Am2017-413 |
0.312 |
|
2016 |
Lo F, Austin S, Howard K, McWhorter M, Collins H, Leonti A, Maassel L, Subia C, Saloranta T, Christopherson N, Shiji K, Patil S, Tahir S, Dow S, Anderson E, ... ... Yeatman T, et al. Abstract 3946: Stratification of metastatic colorectal cancer patients using DNA and RNA sequencing and in-silico prediction of tumor antigens for consideration in immunotherapy Cancer Research. 76: 3946-3946. DOI: 10.1158/1538-7445.Am2016-3946 |
0.389 |
|
2015 |
Kothari N, Kim R, Jorissen RN, Desai J, Tie J, Wong HL, Farragher I, Jones I, Day FL, Li S, Sakthinandeswaren A, Palmieri M, Lipton L, Schell M, Teer JK, ... ... Yeatman T, et al. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. Acta Oncologica (Stockholm, Sweden). 54: 487-92. PMID 25549537 DOI: 10.3109/0284186X.2014.990158 |
0.344 |
|
2015 |
Austin S, Lo FY, Howard K, McWhorter M, Collins H, Leonti A, Maassel L, Subia C, Saloranta T, Heying N, Ritter L, Deutsch K, Cox J, Anderson S, Madan A, ... Yeatman T, et al. Abstract 4842: Pharmacodynamic stratification of metastatic colorectal cancer patients using genomic datasets Cancer Research. 75: 4842-4842. DOI: 10.1158/1538-7445.Am2015-4842 |
0.384 |
|
2015 |
Omolo B, Centeno B, Yeatman T. Abstract 2186: Validation of a 32-gene classifier for the subtyping of carcinomas using the qNPA™ ArrayPlate Platform Cancer Research. 75: 2186-2186. DOI: 10.1158/1538-7445.Am2015-2186 |
0.315 |
|
2014 |
Kothari N, Schell MJ, Teer JK, Yeatman T, Shibata D, Kim R. Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing. Journal of Clinical Pathology. 67: 764-7. PMID 25004944 DOI: 10.1136/Jclinpath-2014-202405 |
0.335 |
|
2014 |
Lee CG, McCarthy S, Gruidl M, Timme C, Yeatman TJ. MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance. Plos One. 9: e84597. PMID 24454732 DOI: 10.1371/Journal.Pone.0084597 |
0.651 |
|
2013 |
Timme CR, Gruidl M, Yeatman TJ. Gamma-secretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 18: 1163-74. PMID 23887890 DOI: 10.1007/S10495-013-0883-X |
0.653 |
|
2013 |
Wey JP, McCarthy S, Chen YA, Fisher K, Kasprzak A, Lloyd M, Qu X, Yeatman T, Klapman J, Coppola D, Malafa M. Abstract LB-70: Tackling a clinical challenge: Using microRNAs to differentiate between low-and high-risk Pancreatic Cysts . Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-70 |
0.346 |
|
2012 |
Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D. A phase II study of RO4929097 in metastatic colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 48: 997-1003. PMID 22445247 DOI: 10.1016/J.Ejca.2012.02.056 |
0.393 |
|
2012 |
Chen DT, Hernandez JM, Shibata D, McCarthy SM, Humphries LA, Clark W, Elahi A, Gruidl M, Coppola D, Yeatman T. Complementary strand microRNAs mediate acquisition of metastatic potential in colonic adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 905-12; discussion 9. PMID 22362069 DOI: 10.1007/S11605-011-1815-0 |
0.301 |
|
2011 |
Mathur R, Schaffer JD, Land WH, Heine JJ, Hernandez JM, Yeatman T. Perturbation and candidate analysis to combat overfitting of gene expression microarray data. International Journal of Computational Biology and Drug Design. 4: 307-15. PMID 22199032 DOI: 10.1504/Ijcbdd.2011.044443 |
0.312 |
|
2011 |
Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D. Expression of the antiapoptotic protein survivin in colon cancer. Clinical Colorectal Cancer. 10: 188-93. PMID 21855041 DOI: 10.1016/j.clcc.2011.03.014 |
0.312 |
|
2011 |
Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mulé JJ. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. The American Journal of Pathology. 179: 37-45. PMID 21703392 DOI: 10.1016/J.Ajpath.2011.03.007 |
0.315 |
|
2011 |
Remily-Wood ER, Liu RZ, Xiang Y, Chen Y, Thomas CE, Rajyaguru N, Kaufman LM, Ochoa JE, Hazlehurst L, Pinilla-Ibarz J, Lancet J, Zhang G, Haura E, Shibata D, Yeatman T, et al. A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics. Clinical Applications. 5: 383-96. PMID 21656910 DOI: 10.1002/Prca.201000115 |
0.325 |
|
2011 |
Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, Mittal MK, Krishnan M, Chen X, Eschrich S, Yeatman TJ, Harris RC, Washington MK, Wilson KT, Beauchamp RD, Singh AB. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Oncogene. 30: 3234-47. PMID 21383692 DOI: 10.1038/Onc.2011.43 |
0.334 |
|
2011 |
Hernandez J, Elahi A, Wang J, Centeno B, Bloom G, Humphries L, Clark W, Tanabe K, Fuchs B, Yeatman T, Shibata D. MiR-675 Mediated Deregulation Of The Rb-E2F Pathway In Hepatocellular Carcinoma Journal of Surgical Research. 165: 291-292. DOI: 10.1016/J.Jss.2010.11.388 |
0.33 |
|
2010 |
Chen Y, Gruidl M, Remily-Wood E, Liu RZ, Eschrich S, Lloyd M, Nasir A, Bui MM, Huang E, Shibata D, Yeatman T, Koomen JM. Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry. Journal of Proteome Research. 9: 4215-27. PMID 20590165 DOI: 10.1021/Pr1005197 |
0.326 |
|
2010 |
Efferson CL, Winkelmann CT, Ware C, Sullivan T, Giampaoli S, Tammam J, Patel S, Mesiti G, Reilly JF, Gibson RE, Buser C, Yeatman T, Coppola D, Winter C, Clark EA, et al. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Cancer Research. 70: 2476-84. PMID 20197467 DOI: 10.1158/0008-5472.Can-09-3114 |
0.382 |
|
2010 |
Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, ... ... Yeatman TJ, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 138: 958-68. PMID 19914252 DOI: 10.1053/J.Gastro.2009.11.005 |
0.31 |
|
2010 |
Krishnan M, Singh AB, Smith JJ, Sharma A, Chen X, Eschrich S, Yeatman TJ, Beauchamp RD, Dhawan P. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Oncogene. 29: 305-12. PMID 19881542 DOI: 10.1038/Onc.2009.324 |
0.445 |
|
2010 |
Chen DT, Nasir A, Venkataramu C, Fulp W, Gruidl M, Yeatman T. Evaluation of malignancy-risk gene signature in breast cancer patients. Breast Cancer Research and Treatment. 120: 25-34. PMID 19306088 DOI: 10.1007/S10549-009-0357-6 |
0.386 |
|
2010 |
Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, Bloom G, Anderson T, White J, Quackenbush J, Yeatman T. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Research and Treatment. 119: 335-46. PMID 19266279 DOI: 10.1007/S10549-009-0344-Y |
0.319 |
|
2009 |
Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. The Journal of Biological Chemistry. 284: 18210-7. PMID 19433578 DOI: 10.1074/Jbc.M109.000034 |
0.457 |
|
2008 |
Coppola D, Khalil F, Eschrich SA, Boulware D, Yeatman T, Wang HG. Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer. 113: 2665-70. PMID 18833585 DOI: 10.1002/Cncr.23892 |
0.363 |
|
2008 |
Chen DT, Schell MJ, Chen JJ, Fulp WJ, Eschrich S, Yeatman T. A predictive risk probability approach for microarray data with survival as an endpoint. Journal of Biopharmaceutical Statistics. 18: 841-52. PMID 18781520 DOI: 10.1080/10543400802277967 |
0.304 |
|
2008 |
Li CG, Gruidl M, Eschrich S, McCarthy S, Wang HG, Alexandrow MG, Yeatman TJ. Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis. International Journal of Cancer. Journal International Du Cancer. 123: 273-82. PMID 18464289 DOI: 10.1002/Ijc.23510 |
0.36 |
|
2008 |
Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ, Wang XF. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes & Development. 22: 308-21. PMID 18245446 DOI: 10.1101/Gad.1632008 |
0.321 |
|
2008 |
Gilkes DM, Pan Y, Coppola D, Yeatman T, Reuther GW, Chen J. Regulation of MDMX expression by mitogenic signaling. Molecular and Cellular Biology. 28: 1999-2010. PMID 18172009 DOI: 10.1128/Mcb.01633-07 |
0.346 |
|
2007 |
Saglam O, Garrett CR, Boulware D, Sayegh Z, Shibata D, Malafa M, Yeatman T, Cheng JQ, Sebti S, Coppola D. Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia. Clinical Colorectal Cancer. 6: 652-6. PMID 17945038 DOI: 10.3816/Ccc.2007.N.034 |
0.414 |
|
2006 |
Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B, Pow-Sang J, Yeatman T, Djeu JY. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells Oncogene. 25: 6113-6122. PMID 16652143 DOI: 10.1038/Sj.Onc.1209632 |
0.376 |
|
2005 |
Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, Cantor AB, Scuto A, Li C, Zhang S, Jove R, Yeatman T. Prediction of radiation sensitivity using a gene expression classifier. Cancer Research. 65: 7169-76. PMID 16103067 DOI: 10.1158/0008-5472.Can-05-0656 |
0.349 |
|
2005 |
Kelley ST, Coppola D, Yeatman T, Marcet J. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways. Clinical Colorectal Cancer. 5: 114-8. PMID 16098252 DOI: 10.3816/Ccc.2005.N.023 |
0.314 |
|
2005 |
Cook AC, Tuck AB, McCarthy S, Turner JG, Irby RB, Bloom GC, Yeatman TJ, Chambers AF. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression. Molecular Carcinogenesis. 43: 225-36. PMID 15864800 DOI: 10.1002/Mc.20105 |
0.329 |
|
2004 |
Yeatman T, Rocha Lima CM, Barthel J, Calvin D, Garret C, Dinwoodie WR, Mayfield S, Wright M, Lush R, Sullivan D. Phase I trial of oral topotecan (OT) and radiotherapy (XRT) in rectal cancer (RCA). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3743. PMID 28014109 DOI: 10.1200/Jco.2004.22.90140.3743 |
0.312 |
|
2004 |
Irby RB, McCarthy SM, Yeatman TJ. Osteopontin regulates multiple functions contributing to human colon cancer development and progression Clinical and Experimental Metastasis. 21: 515-523. PMID 15679049 DOI: 10.1007/S10585-004-2873-4 |
0.301 |
|
2004 |
Chen T, Turner J, McCarthy S, Scaltriti M, Bettuzzi S, Yeatman TJ. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Research. 64: 7412-9. PMID 15492264 DOI: 10.1158/0008-5472.Can-04-2077 |
0.333 |
|
2004 |
Nasir A, Boulware D, Kaiser HE, Bodey B, Siegel S, Crawley S, Yeatman T, Marcet JE, Coppola D. Flat and polypoid adenocarcinomas of the colorectum: A comparative histomorphologic analysis of 47 cases. Human Pathology. 35: 604-11. PMID 15138936 DOI: 10.1016/J.Humpath.2003.11.011 |
0.317 |
|
2004 |
Wang JW, Gamsby JJ, Highfill SL, Mora LB, Bloom GC, Yeatman TJ, Pan TC, Ramne AL, Chodosh LA, Cress WD, Chen J, Kerr WG. Deregulated expression of LRBA facilitates cancer cell growth. Oncogene. 23: 4089-97. PMID 15064745 DOI: 10.1038/Sj.Onc.1207567 |
0.352 |
|
2004 |
Nasir A, Kaiser HE, Boulware D, Hakam A, Zhao H, Yeatman T, Barthel J, Coppola D. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. Clinical Colorectal Cancer. 3: 243-7. PMID 15025797 DOI: 10.3816/Ccc.2004.N.005 |
0.397 |
|
2003 |
Chen T, Yang I, Irby R, Shain KH, Wang HG, Quackenbush J, Coppola D, Cheng JQ, Yeatman TJ. Regulation of caspase expression and apoptosis by adenomatous polyposis coli Cancer Research. 63: 4368-4374. PMID 12907606 |
0.305 |
|
2002 |
Reed J, Ouban A, Schickor FK, Muraca P, Yeatman T, Coppola D. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma Clinical Colorectal Cancer. 2: 119-122. DOI: 10.3816/Ccc.2002.N.018 |
0.326 |
|
2001 |
Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression Journal of Surgical Research. 99: 222-227. PMID 11469890 DOI: 10.1006/Jsre.2001.6195 |
0.302 |
|
2001 |
Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 7319-24. PMID 11404481 DOI: 10.1073/Pnas.131568898 |
0.315 |
|
1999 |
Hegde P, Earle-Hughes J, Abernathy K, Dharap S, Saeed AI, Sharov V, Lee NH, Yeatman T, Quackenbush J. Identification of genes involved in colon cancer metastasis using cDNA microarrays Nature Genetics. 23: 50-50. DOI: 10.1038/14322 |
0.391 |
|
1997 |
Yeatman TJ, Mao W, Karl RC. Biliary Glycoprotein Is Overexpressed in Human Colon Cancer Cells with High Metastatic Potential Journal of Gastrointestinal Surgery. 1: 292-298. PMID 9834361 |
0.321 |
|
1995 |
Reintgen D, Lyman G, Yeatman T, Cox C. Non-operative observation of mammographic abnormalities: Medical legal implications Breast Journal. 1: 262-267. DOI: 10.1111/J.1524-4741.1995.Tb00248.X |
0.332 |
|
Show low-probability matches. |